Direct-to-Consumer Medical Testing in the Era of Value-Based Care

JAMA. 2017 Jun 27;317(24):2485-2486. doi: 10.1001/jama.2017.5929.

Author

Kimberly Lovett Rockwell¹

Affiliation

¹ Honigman Miller Schwartz & Cohn LLP, Bloomfield Hills, Michigan.

PMID: 28542699
DOI: 10.1001/jama.2017.5929

No abstract available

MeSH terms

Cost Control
Delivery of Health Care / economics
Delivery of Health Care / standards
Direct-To-Consumer Screening and Testing* / economics
Direct-To-Consumer Screening and Testing* / legislation & jurisprudence
Direct-To-Consumer Screening and Testing* / trends
Genetic Testing
Health Care Costs
Health Services Misuse / economics
Health Services Misuse / prevention & control*
Health Services Misuse / trends
Humans
Quality of Health Care / economics
Quality of Health Care / standards
State Government
United States
United States Federal Trade Commission
United States Food and Drug Administration
Unnecessary Procedures* / economics
Unnecessary Procedures* / trends